mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
mRNA |
Topotecan |
FIMM |
pan-cancer |
AAC |
0.0091 |
0.9 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
0.0022 |
0.9 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |